Richard Beckman, Chief Medical Officer at Adverum Biotechnologies, Inc. (ADVM), bought 10,000 shares at $0.82 ($8K) on 2022-05-17, disclosed to the SEC on 2022-05-19.
Open-market purchase of $8k ADVM by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.